Jarl Ulf
medical officer
medicine
Chemical Computing Group
Bahamas
Biography
Jarl Ulf Jungnelius, MD, PhD worked at Celgene from 2007 to 2014 where he served as Vice President of Clinical Research and Development, Solid Tumors. Prior to that post Dr. Jungnelius held leadership positions at Takeda, Pfizer and Eli Lilly & Company, where he was responsible for clinical development of oncology programs as well as involved in business development.
Research Interest
oncopedics
